Press "Enter" to skip to content

Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study

Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study
To assess the safety and efficacy of four vilaprisan doses (0.5–4.0 mg) in women with uterine fibroids.
Source: fertstert.org

Be First to Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.